Psychedelic Research

As research continues & more data becomes available, we will deepen our understanding of the impact that psychedelics have in reducing the economic and health burden of mental health disorders.

Study provides preliminary support for the safety and efficacy of psilocybin for treatment-resistant depression.

Study finds that high-dose psilocybin produced large decreases in measures of depressed mood and anxiety, along with increases in quality of life, life meaning, and optimism, and decreases in death anxiety.

A Recent Clinical Trial Examined This Important Question: Is Psilocybin-Assisted Therapy Efficacious Among Patients With Major Depressive Disorder?